NCT01344876: Phase I Study of OPB-51602 in Patients With Hematologic Malignancies |
|
|
| Completed | 1 | 20 | Japan | OPB-51602 | Otsuka Pharmaceutical Co., Ltd. | Multiple Myeloma, Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Chronic Myeloid Leukemia | 04/14 | 04/14 | | |
